Founder-led Deep-Tech MedTech Simulation SaaS

Software-first simulation for biomedical micro-robotics R&D.

MAM Nexus is building a non-clinical CAE simulation platform for researchers, biomedical engineering teams, and early-stage MedTech innovators working on RF-controlled micro-robotics and untethered intraluminal systems.

Platform Focus

A focused simulation layer for early-stage engineering exploration before expensive physical prototyping, fabrication, or clinical translation.

CAE Simulation SaaS

A software-first environment for modeling and exploring early biomedical micro-robotic system behavior.

RF Control Modeling

Focused on synchronization, control logic, and motion behavior for RF-enabled untethered device concepts.

Non-clinical R&D

Built for engineering research and technical feasibility exploration, not for direct patient treatment or clinical deployment.

Why It Matters

Biomedical micro-robotics and intraluminal device research often requires expensive prototyping, fragmented simulation workflows, and long experimental cycles.

MAM Nexus aims to reduce early-stage R&D friction by helping teams explore control logic, motion feasibility, and system behavior before committing to hardware.

Biomedical micro-robotics Intraluminal systems RF synchronization CAE simulation MedTech R&D
Important positioning

MAM Nexus is not presented as a clinically approved medical device or a hospital-ready surgical robot. It is positioned as a non-clinical engineering simulation and R&D platform.

Founder

Eng. Mahmoud Alqadi

Founder & Principal Systems Innovator

Electrical and biomedical engineering background with experience across biomedical instrumentation, diagnostics, medical device quality/regulatory workflows, robotics systems, and deep-tech R&D.

MAM Nexus is founder-led and built around documented technical foundations, simulation direction, and strategic positioning for research, startup, and deep-tech innovation ecosystems.

Contact

For research collaboration, incubation, partnership, or startup program inquiries: